Patricia A. Escobar

1.4k citations

21 papers · 826 indexed · h-index 13

Cancer Research top 5%
Health, Toxicology and Mutagenesis top 5%
Molecular Biology
Plant Science top 10%
Food Science top 10%

Co-authors: Brian Burlinson Yoshifumi Uno Marie Vasquez Günter Speit Andrew Collins Raymond R. Tice Madoka Nakajima Andreas Hartmann
Topics: Carcinogens and Genotoxicity Assessment (15 papers)Genetically Modified Organisms Research (6 papers)Effects and risks of endocrine disrupting chemicals (5 papers)
Cited by: Chemical Health and Safety Cancer Research Health, Toxicology and Mutagenesis
Journals: Toxicological Sciences Mutation Research/Reviews in Mutation Research Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Partner nations: United States United Kingdom Germany

In The Last Decade

Patricia A. Escobar

21 papers receiving 797 citations

Peers

Countries citing papers authored by Patricia A. Escobar

Since Specialization

Citations

This map shows the geographic impact of Patricia A. Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Escobar more than expected).

Fields of papers citing papers by Patricia A. Escobar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Escobar. The network helps show where Patricia A. Escobar may publish in the future.

Co-authorship network of co-authors of Patricia A. Escobar

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia A. Escobar. A scholar is included among the top collaborators of Patricia A. Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia A. Escobar. Patricia A. Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP 2024 ·Regulatory Toxicology and Pharmacology ·Mark W. Powley,Zhanna Sobol,George E. Johnson,Robert W. Clark,(unknown),(unknown),(unknown),Mark D. Mowery,Patricia A. Escobar	8
2	Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir 2024 ·Toxicological Sciences ·Patricia A. Escobar,Zhanna Sobol,Randy R. Miller,(unknown),(unknown),(unknown),Nagaraja Muniappa,Rosa I. Sánchez,Kerry T. Blanchard,(unknown),Rupesh P. Amin,Sean P. Troth	5
3	Next Generation Sequencing Workshop at the Royal Society of Medicine (London, May 2022): how genomics is on the path to modernizing genetic toxicology 2023 ·Mutagenesis ·(unknown),(unknown),Jesse J. Salk,Iñigo Martincorena,Robert R. Young,Jill E. Kucab,Charles C. Valentine,Carole L. Yauk,Patricia A. Escobar,Kristine L. Witt,Roland Frötschl,Simon H. Reed,A. E. Ashford	3
4	Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine 2023 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Joel P. Bercu,Shaofei Zhang,Zhanna Sobol,Patricia A. Escobar,(unknown),Maik Schuler	24
5	Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines 2022 ·Regulatory Toxicology and Pharmacology ·Alejandra Trejo‐Martin,Joel P. Bercu,(unknown),Rachael E. Tennant,Robert Thomas,Kevin P. Cross,Andreas Czich,(unknown),John Nicolette,Joel Murray,(unknown),(unknown),(unknown),D. Thomas,Anthony Lynch,James Harvey,Susanne Glowienke,Laura Custer,Patricia A. Escobar	31
6	A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies 2022 ·Toxicological Sciences ·J. Christopher Corton,Constance A. Mitchell,Scott S. Auerbach,Pierre R. Bushel,Heidrun Ellinger‐Ziegelbauer,Patricia A. Escobar,Roland Froetschl,Alison H. Harrill,Kamin J. Johnson,James E. Klaunig,Arun R. Pandiri,Alexei A. Podtelezhnikov,Julia E. Rager,Keith Q. Tanis,Jan Willem van der Laan,(unknown),Carole L. Yauk,Syril Pettit,Frank D. Sistare	15
7	Revisiting the bacterial mutagenicity assays: Report by a workgroup of the International Workshops on Genotoxicity Testing (IWGT) 2020 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Rita Schoeny,Kevin P. Cross,David M. DeMarini,Rosalie K. Elespuru,Atsushi Hakura,Dan D. Levy,Richard V. Williams,Errol Zeiger,Patricia A. Escobar,Jonathan Howe,Masayuki Kato,(unknown),Martha M. Moore,Stéphanie Simon,Leon F. Stankowski,Kei‐ichi Sugiyama,Bas‐jan M. van der Leede	6
8	Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective 2020 ·Regulatory Toxicology and Pharmacology ·Vincent L. Reynolds,Paul Butler,(unknown),Laura Aschenbrenner,Derek Best,(unknown),Meredith E. Crosby,Laura Custer,Patricia A. Escobar,Kyle L. Kolaja,Jonathan G. Moggs,Dana Shuey,(unknown),Terry Van Vleet,(unknown),Timothy K. Hart	1
9	Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test) 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Dan D. Levy,Errol Zeiger,Patricia A. Escobar,Atsushi Hakura,Bas‐jan M. van der Leede,Masayuki Kato,Martha M. Moore,Kei‐ichi Sugiyama	65
10	Analysis of historical negative control group data from the rat in vivo micronucleus assay 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·David P. Lovell,Mick D. Fellows,(unknown),James Whitwell,Laura Custer,Stephen D. Dertinger,Patricia A. Escobar,(unknown),Ulrike Hemmann,Julia Kenny,Robert Smith,Bas‐jan M. van der Leede,Andreas Zeller	2
11	Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed? 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Richard V. Williams,David M. DeMarini,Leon F. Stankowski,Patricia A. Escobar,Errol Zeiger,Jonathan Howe,Rosalie K. Elespuru,Kevin P. Cross	47
12	Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy 2019 ·Environmental and Molecular Mutagenesis ·Stephen D. Dertinger,Andrew R. Kraynak,(unknown),(unknown),Steven M. Bryce,Nikki E. Hall,Jeffrey C. Bemis,Sheila M. Galloway,Patricia A. Escobar,George E. Johnson	31
13	Demonstrating laboratory proficiency in bacterial mutagenicity assays for regulatory submission 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Dan D. Levy,Atsushi Hakura,Rosalie K. Elespuru,Patricia A. Escobar,Masayuki Kato,(unknown),Martha M. Moore,Kei‐ichi Sugiyama	16
14	In Vivo Mutagenicity Testing of Arylboronic Acids and Esters 2019 ·Environmental and Molecular Mutagenesis ·(unknown),Krista L. Dobo,Michelle Kenyon,Julia Kenny,Sheila M. Galloway,Patricia A. Escobar,M. Vijayaraj Reddy,Robert A. Jolly,Alejandra Trejo‐Martin,(unknown),(unknown),M. B. Young,(unknown),Kamala Pant,(unknown),Rohan Kulkarni,Joel P. Bercu	10
15	JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for the detection of genotoxic carcinogens: I. Summary of pre-validation study results 2015 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Yoshifumi Uno,Hajime Kojima,Takashi Omori,Raffaella Corvi,(unknown),Leonard M. Schechtman,Raymond R. Tice,Brian Burlinson,Patricia A. Escobar,Andrew R. Kraynak,Yuzuki Nakagawa,Madoka Nakajima,Kamala Pant,Norihide Asano,David Lovell,Takeshi Morita,Yasuo Ohno,Makoto Hayashi	13
16	Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT) 2014 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Günter Speit,Hajime Kojima,Brian Burlinson,Andrew Collins,Peter Kasper,Ulla Plappert‐Helbig,Yoshifumi Uno,Marie Vasquez,Carol Beevers,Marlies De Boeck,Patricia A. Escobar,Sachiko Kitamoto,Kamala Pant,Stefan Pfuhler,Jin Tanaka,Dan D. Levy	49
17	Bacterial mutagenicity screening in the pharmaceutical industry 2012 ·Mutation Research/Reviews in Mutation Research ·Patricia A. Escobar,Raymond A. Kemper,(unknown),John Nicolette,Michelle Kenyon,Susanne Glowienke,Satin G. Sawant,(unknown),Timothy E. Johnson,Crystal McKnight,(unknown),Sheila M. Galloway,Laura Custer,Elmar Gocke,Mike O’Donovan,(unknown),Ronald D. Snyder,Brinda Mahadevan	49
18	Coupling cytotoxicity biomarkers with DNA damage assessment in TK6 human lymphoblast cells 2010 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Jing Shi,Sandra A. Springer,Patricia A. Escobar	20
19	Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH) 2007 ·Mutagenesis ·Patricia A. Escobar,Martyn T. Smith,(unknown),Alan Hubbard,(unknown)	37
20	Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup 2006 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Brian Burlinson,Raymond R. Tice,Günter Speit,Eva Agurell,Susanne Brendler‐Schwaab,Andrew Collins,Patricia A. Escobar,Masamitsu Honma,T. S. Kumaravel,Madoka Nakajima,Yū F. Sasaki,Véronique Thybaud,Yoshifumi Uno,Marie Vasquez,Andreas Hartmann	392

About Patricia A. Escobar

Patricia A. Escobar is a scholar working on Cancer Research, Small Animals and Health, Toxicology and Mutagenesis, having authored 21 papers that have together received 826 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (15 papers), Genetically Modified Organisms Research (6 papers) and Effects and risks of endocrine disrupting chemicals (5 papers). The work is most often cited by research in Chemical Health and Safety (25 citations), Cancer Research (473 citations) and Health, Toxicology and Mutagenesis (266 citations). Patricia A. Escobar has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Brian Burlinson, Yoshifumi Uno, Marie Vasquez, Günter Speit, Andrew Collins, Raymond R. Tice, Madoka Nakajima, Andreas Hartmann, Eva Agurell and Yū F. Sasaki. Their work appears in journals such as Toxicological Sciences, Mutation Research/Reviews in Mutation Research and Mutation Research/Genetic Toxicology and Environmental Mutagenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact